Concise Review: Stem Cell-based Approaches to Red Blood Cell Production for Transfusion

Overview

Journal Stem Cells Transl Med

Publisher Oxford University Press

Specialties Cell Biology
Pharmacology

Date 2013 Dec 24

PMID 24361925

Citations 28

Authors

Siddharth Shah

Xiaosong Huang

Linzhao Cheng

Affiliations

Soon will be listed here.

Abstract

Blood transfusion is a common procedure in modern medicine, and it is practiced throughout the world; however, many countries report a less than sufficient blood supply. Even in developed countries where the supply is currently adequate, projected demographics predict an insufficient supply as early as 2050. The blood supply is also strained during occasional widespread disasters and crises. Transfusion of blood components such as red blood cells (RBCs), platelets, or neutrophils is increasingly used from the same blood unit for multiple purposes and to reduce alloimmune responses. Even for RBCs and platelets lacking nuclei and many antigenic cell-surface molecules, alloimmunity could occur, especially in patients with chronic transfusion requirements. Once alloimmunization occurs, such patients require RBCs from donors with a different blood group antigen combination, making it a challenge to find donors after every successive episode of alloimmunization. Alternative blood substitutes such as synthetic oxygen carriers have so far proven unsuccessful. In this review, we focus on current research and technologies that permit RBC production ex vivo from hematopoietic stem cells, pluripotent stem cells, and immortalized erythroid precursors.

Citing Articles

Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases.

Mohanto N, Mondal H, Park Y, Jee J J Nanobiotechnology. 2025; 23(1):25.

PMID: 39827150 PMC: 11742488. DOI: 10.1186/s12951-024-03060-9.

In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs).

Chukwuemeka C, Ndubueze C, Kolawole A, Joseph J, Oladipo I, Ofoezie E Blood Sci. 2024; 7(1):e00215.

PMID: 39726795 PMC: 11671056. DOI: 10.1097/BS9.0000000000000215.

Differentiating erythroblasts adapt to mechanical stimulation by upregulation of cholesterol biosynthesis via S1P/SREBP-induced HMGCR expression.

Iacono G, Abay A, Murillo J, Aglialoro F, Yagci N, Varga E Sci Rep. 2024; 14(1):30157.

PMID: 39627481 PMC: 11615233. DOI: 10.1038/s41598-024-81746-8.

Detection of CRISPR/Cas9-Mediated Fetal Hemoglobin Reactivation in Erythroblasts Derived from Cord Blood-Hematopoietic Stem Cells.

Maroofi N, Sadat Mousavi Maleki M, Tahmasebi M, Khorshid H, Modaberi Y, Najafipour R Mol Biotechnol. 2024; .

PMID: 38649638 DOI: 10.1007/s12033-024-01155-0.

An Optimized Human Erythroblast Differentiation System Reveals Cholesterol-Dependency of Robust Production of Cultured Red Blood Cells Ex Vivo.

Wang E, Liu S, Zhang X, Peng Q, Yu H, Gao L Adv Sci (Weinh). 2024; 11(22):e2303471.

PMID: 38481061 PMC: 11165465. DOI: 10.1002/advs.202303471.

References

Kim C, Epner E, Forrester W, Groudine M . Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. Genes Dev. 1992; 6(6):928-38. DOI: 10.1101/gad.6.6.928. View

Giarratana M, Rouard H, Dumont A, Kiger L, Safeukui I, Le Pennec P . Proof of principle for transfusion of in vitro-generated red blood cells. Blood. 2011; 118(19):5071-9. PMC: 3217398. DOI: 10.1182/blood-2011-06-362038. View

Hao Q, Shah A, Thiemann F, Smogorzewska E, Crooks G . A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood. 1995; 86(10):3745-53. View

Nakamura Y, Hiroyama T, Miharada K, Kurita R . Red blood cell production from immortalized progenitor cell line. Int J Hematol. 2010; 93(1):5-9. DOI: 10.1007/s12185-010-0742-2. View

Fujimi A, Matsunaga T, Kobune M, Kawano Y, Nagaya T, Tanaka I . Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages. Int J Hematol. 2008; 87(4):339-350. DOI: 10.1007/s12185-008-0062-y. View

Feng Q, Lu S, Klimanskaya I, Gomes I, Kim D, Chung Y . Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010; 28(4):704-12. DOI: 10.1002/stem.321. View

Adams R, McKie V, Hsu L, Files B, Vichinsky E, Pegelow C . Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998; 339(1):5-11. DOI: 10.1056/NEJM199807023390102. View

Poole J, Daniels G . Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2006; 21(1):58-71. DOI: 10.1016/j.tmrv.2006.08.003. View

Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y . Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006; 24(10):1255-6. DOI: 10.1038/nbt1245. View

10.

Rochette J, Craig J, Thein S . Fetal hemoglobin levels in adults. Blood Rev. 1994; 8(4):213-24. DOI: 10.1016/0268-960x(94)90109-0. View

11.

Zou J, Mali P, Huang X, Dowey S, Cheng L . Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood. 2011; 118(17):4599-608. PMC: 3208277. DOI: 10.1182/blood-2011-02-335554. View

12.

Yazdanbakhsh K, Ware R, Noizat-Pirenne F . Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012; 120(3):528-37. PMC: 3401213. DOI: 10.1182/blood-2011-11-327361. View

13.

Chou B, Mali P, Huang X, Ye Z, Dowey S, Resar L . Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011; 21(3):518-29. PMC: 3193421. DOI: 10.1038/cr.2011.12. View

14.

Szabo E, Rampalli S, Risueno R, Schnerch A, Mitchell R, Fiebig-Comyn A . Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010; 468(7323):521-6. DOI: 10.1038/nature09591. View

15.

Migliaccio A . Erythroblast enucleation. Haematologica. 2010; 95(12):1985-8. PMC: 2995553. DOI: 10.3324/haematol.2010.033225. View

16.

Daniels G, Castilho L, Flegel W, Fletcher A, Garratty G, Levene C . International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang. 2009; 96(2):153-6. DOI: 10.1111/j.1423-0410.2008.01133.x. View

17.

Hiroyama T, Miharada K, Sudo K, Danjo I, Aoki N, Nakamura Y . Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One. 2008; 3(2):e1544. PMC: 2212133. DOI: 10.1371/journal.pone.0001544. View

18.

Esteghamat F, Gillemans N, Bilic I, van den Akker E, Cantu I, van Gent T . Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice. Blood. 2013; 121(13):2553-62. DOI: 10.1182/blood-2012-06-434530. View

19.

Migliaccio G, Di Pietro R, di Giacomo V, Di Baldassarre A, Migliaccio A, Maccioni L . In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002; 28(2):169-80. DOI: 10.1006/bcmd.2002.0502. View

20.

Silverman T, Weiskopf R . Hemoglobin-based oxygen carriers: current status and future directions. Transfusion. 2009; 49(11):2495-515. DOI: 10.1111/j.1537-2995.2009.02356.x. View